Lemaitre Vascular (LMAT) Asset Writedowns and Impairment (2010 - 2025)

Lemaitre Vascular (LMAT) has 16 years of Asset Writedowns and Impairment data on file, last reported at $362000.0 in Q4 2025.

• On a quarterly basis, Asset Writedowns and Impairment rose 127.82% year-over-year to $362000.0 in Q4 2025; TTM through Mar 2026 was $180000.0, a 75.48% decrease from a year earlier, with the FY2025 full-year figure at $817000.0, changed 0.49% from the prior year.
• Asset Writedowns and Impairment for Q4 2025 stood at $362000.0, up from -$575000.0 in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for LMAT reached as high as $2.2 million in Q4 2023 and fell as low as -$2.0 million in Q3 2021.
• Historically, Asset Writedowns and Impairment has averaged $238350.0 across 5 years, with a median of $391000.0 in 2022.
• Across the five-year window, Asset Writedowns and Impairment tumbled 1220.47% in 2022 and jumped 10328.57% in 2024, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at $127000.0 in 2021, then tumbled by 1220.47% to -$1.4 million in 2022, then soared by 252.99% to $2.2 million in 2023, then slumped by 159.76% to -$1.3 million in 2024, then surged by 127.82% to $362000.0 in 2025.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $362000.0 in Q4 2025, -$575000.0 in Q3 2025, and $393000.0 in Q2 2025.